Cwm, LLC Mustang Bio, Inc. Transaction History

Cwm, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Sep 15, 2021	BUY	$3.01 - $3.88 $6,020 - $7,760	2,000 New	2,000 $7,000
Q3 2020 Oct 19, 2020	SELL	$3.01 - $3.88 $6,020 - $7,760	-2,000 Closed	0 $0
Q2 2020 Sep 15, 2021	BUY	$2.33 - $4.6 $4,660 - $9,200	2,000 New	2,000 $7,000
Q2 2020 Jul 22, 2020	SELL	$2.33 - $4.6 $4,660 - $9,200	-2,000 Closed	0 $0
Q1 2020 Sep 15, 2021	BUY	$1.91 - $4.52 $3,820 - $9,040	2,000 New	2,000 $7,000
Q1 2020 Apr 28, 2020	SELL	$1.91 - $4.52 $3,820 - $9,040	-2,000 Closed	0 $0
Q4 2019 Sep 14, 2021	BUY	$2.57 - $4.08 $5,140 - $8,160	2,000 New	2,000 $7,000
Q4 2019 Jan 27, 2020	SELL	$2.57 - $4.08 $5,140 - $8,160	-2,000 Closed	0 $0
Q3 2019 Sep 14, 2021	BUY	$2.74 - $4.65 $5,480 - $9,300	2,000 New	2,000 $7,000
Q3 2019 Oct 22, 2019	SELL	$2.74 - $4.65 $5,480 - $9,300	-2,000 Closed	0 $0
Q2 2019 Sep 14, 2021	BUY	$2.66 - $6.28 $5,320 - $12,560	2,000 New	2,000 $7,000
Q2 2019 Jul 31, 2019	SELL	$2.66 - $6.28 $5,320 - $12,560	-2,000 Closed	0 $0
Q1 2019 Sep 02, 2021	BUY	$2.95 - $5.61 $5,900 - $11,220	2,000 New	2,000 $0

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $20M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

Stay updated on Cwm, LLC with notifications on news.